1. Methodology: As of 6/30/19, self-reported data from over 16,000 bronchiectasis patients.
2. RespirTech's bronchiectasis patient outcomes program consists of follow-up calls at periodic intervals for up to two years to encourage HFCWO adherence and ensure the device is properly set for individual needs.
3. Plioplys AV, Lewis S, Kasnicka I. Pulmonary vest therapy in pediatric long-term care. J Am Med Dir Assoc 2002;3(5):318-321. Note: Study of 7 quadriplegic cerebral palsy patients, 4 having epilepsy.